AwesomeCapital
Search This Blog
Monday, April 22, 2024
Panbela Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
Trial's lower-than-expected event rate suggests improved survival outcomes
https://www.globenewswire.com/news-release/2024/04/22/2866820/37414/en/Panbela-Therapeutics-Announces-Interim-Data-Analysis-for-ASPIRE-Trial-Pushed-to-Q1-2025.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.